About

Eli Lilly Logo

Tirzepatide Once Weekly for the Treatment of Obesity

FDA approves subcutaneous tirzepatide injection (Mounjaro™) for Type 2 Diabetes

New Ozempic Dose Approved by FDA

Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes

Steering Committee